ENZO BIOCHEM, INC. Retained Earnings
ENZO BIOCHEM, INC. had Retained Earnings of -$302.13 million as of 2025-04-30, per its 10-Q filed 2025-06-16.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-06-16
- 2025-04-30: Retained Earnings (Accumulated Deficit) -$302.13M.
- 2025-01-31: Retained Earnings (Accumulated Deficit) -$299.34M.
- 2024-10-31: Retained Earnings (Accumulated Deficit) -$297.80M.
- 2024-07-31: Retained Earnings (Accumulated Deficit) -$294.43M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-04-30 | -$302.13M 10-Q · filed 2025-06-16 |
| 2025-01-31 | -$299.34M 10-Q · filed 2025-03-17 |
| 2024-10-31 | -$297.80M 10-Q · filed 2024-12-16 |
| 2024-07-31 | -$294.43M 10-Q · filed 2025-06-16 |
| 2024-04-30 | -$281.05M 10-Q · filed 2024-06-13 |
| 2024-01-31 | -$278.03M 10-Q · filed 2024-03-13 |
| 2023-10-31 | -$274.97M 10-Q · filed 2023-12-15 |
| 2023-07-31 | -$268.35M 10-K · filed 2024-10-29 |
| 2023-04-30 | -$325.78M 10-Q · filed 2023-06-14 |
| 2023-01-31 | -$310.59M 10-Q · filed 2023-03-20 |
| 2022-10-31 | -$299.27M 10-Q · filed 2022-12-12 |
| 2022-07-31 | -$288.64M 10-K · filed 2023-11-03 |
| 2022-04-30 | -$280.20M 10-Q · filed 2022-06-09 |
| 2022-01-31 | -$275.35M 10-Q · filed 2022-03-14 |
| 2021-10-31 | -$272.70M 10-Q · filed 2021-12-15 |
| 2021-07-31 | -$270.38M 10-K · filed 2022-10-14 |
| 2021-04-30 | -$273.64M 10-Q · filed 2021-06-11 |
| 2021-01-31 | -$275.65M 10-Q · filed 2021-03-16 |
| 2020-10-31 | -$277.95M 10-Q · filed 2020-12-11 |
| 2020-07-31 | -$278.25M 10-K · filed 2021-10-12 |
| 2020-04-30 | -$274.93M 10-Q · filed 2020-06-09 |
| 2020-01-31 | -$265.07M 10-Q · filed 2020-03-06 |
| 2019-10-31 | -$257.38M 10-Q · filed 2019-12-10 |
| 2019-07-31 | -$249.73M 10-K · filed 2020-10-19 |
| 2019-04-30 | -$244.34M 10-Q · filed 2019-06-10 |
| 2019-01-31 | -$266.61M 10-Q · filed 2019-03-11 |
| 2018-10-31 | -$258.20M 10-Q · filed 2018-12-10 |
| 2018-07-31 | -$252.22M 10-K · filed 2019-10-15 |
| 2018-04-30 | -$246.46M 10-Q · filed 2018-06-11 |
| 2018-01-31 | -$243.44M 10-Q · filed 2018-03-12 |
| 2017-10-31 | -$242.54M 10-Q · filed 2017-12-07 |
| 2017-07-31 | -$241.90M 10-K · filed 2018-10-15 |
| 2017-04-30 | -$241.99M 10-Q · filed 2017-06-08 |
| 2017-01-31 | -$241.92M 10-Q · filed 2017-03-13 |
| 2016-10-31 | -$240.87M 10-Q · filed 2016-12-08 |
| 2016-07-31 | -$239.40M 10-K · filed 2017-09-27 |
| 2016-04-30 | -$275.53M 10-Q · filed 2016-06-08 |
| 2016-01-31 | -$273.42M 10-Q · filed 2016-03-09 |
| 2015-10-31 | -$280.25M 10-Q · filed 2015-12-08 |
| 2015-07-31 | -$284.68M 10-K · filed 2016-10-13 |
| 2015-04-30 | -$293.12M 10-Q · filed 2015-06-09 |
| 2015-01-31 | -$290.22M 10-Q · filed 2015-03-12 |
| 2014-10-31 | -$286.13M 10-Q · filed 2014-12-09 |
| 2014-07-31 | -$282.40M 10-K · filed 2015-10-13 |
| 2014-04-30 | -$279.23M 10-Q · filed 2014-06-09 |
| 2014-01-31 | -$278.77M 10-Q · filed 2014-03-11 |
| 2013-10-31 | -$275.21M 10-Q · filed 2013-12-10 |
| 2013-07-31 | -$272.42M 10-K · filed 2014-10-09 |
| 2013-04-30 | -$269.32M 10-Q · filed 2013-06-10 |
| 2013-01-31 | -$263.55M 10-Q · filed 2013-03-12 |
| 2012-10-31 | -$257.87M 10-Q · filed 2012-12-10 |
| 2012-07-31 | -$254.18M 10-K · filed 2013-10-15 |
| 2012-04-30 | -$227.04M 10-Q · filed 2012-06-11 |
| 2012-01-31 | -$223.63M 10-Q · filed 2012-03-12 |
| 2011-10-31 | -$219.41M 10-Q · filed 2011-12-12 |
| 2011-07-31 | -$214.91M 10-K · filed 2012-10-15 |